durvalumab
astrazeneca
['caspian', 'sclc']
#asco23 abs#8516
#sclc baseline pros have prognostic value in the caspian trial across different specifications, being discussed at #posterdicussion 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl